Rosenberg M J, Holmes K K
World Health Organization Working Group on Virucides, Geneva, Switzerland.
Sex Transm Dis. 1993 Jan-Feb;20(1):41-4. doi: 10.1097/00007435-199301000-00008.
Vaginal spermicides have microbicidal properties that suggest their usefulness in helping to protect against human immunodeficiency virus (HIV) and other sexually transmitted infections. Laboratory, animal, and clinical investigations also support this notion. Because of the importance of identifying additional methods to protect against these infections, however, better information is needed on these female-controlled methods. A consistent set of laboratory standards is needed to evaluate the in vitro activity of existing and future virucides. Further evaluation of such areas as the actions of virucides and vehicles on different anatomical sites and safety studies to better judge determinants of toxicity are needed. Clinical studies might compare efficacy of spermicides and condoms in prevention of HIV and other sexually transmitted diseases as well as investigate psychosocial considerations that determine suitable candidates for vaginal virucides, how they are used, and how their use might be improved.
阴道杀精剂具有杀菌特性,这表明它们在帮助预防人类免疫缺陷病毒(HIV)和其他性传播感染方面可能有用。实验室、动物和临床研究也支持这一观点。然而,由于确定预防这些感染的其他方法很重要,因此需要关于这些女性控制方法的更完善信息。需要一套一致的实验室标准来评估现有和未来杀病毒剂的体外活性。需要进一步评估杀病毒剂和载体在不同解剖部位的作用等领域,并进行安全性研究,以更好地判断毒性的决定因素。临床研究可以比较杀精剂和避孕套在预防HIV和其他性传播疾病方面的效果,还可以调查心理社会因素,这些因素决定了阴道杀病毒剂的合适使用者、其使用方式以及如何改进其使用方法。